top of page


Ministry of Foreign Affairs of Denmark-I


DKBIO 2022

April 5, 2022

6.00 - 8.00 PM

Informal evening gathering for Scandinavian participants in Boston.

215 Charles St., Boston, MA 02114, United states 

April 6, 2022
700 Technology Square,
Cambridge, MA 02139, United States

8.00 - 8.30 AM 

8.30 - 8.45 AM 

8.45 - 9.30 AM 

Breakfast and registration 

Welcome to DKBIO 2022

Panel debate: Biotech, medtech & dealmaking

Life science experts from some of the largest pharma and healthcare companies in the Boston / Cambridge area share their perspectives on recent developments in external innovation and deal making and what they enjoy about working in the Boston ecosystem 

9.30 - 10.30 AM

Company presentations

10.30 - 11.00 AM 

Networking coffee break

11.00 - 11.45 AM

Panel debate: Experiences from Scandinavia to U.S. 

A number of Scandinavian companies have successfully gone from being small Scandinavian start-ups to conducting US IPOs and establishing a presence in the U.S. With point of departure in Galecto’s and Genmab’s experiences, this session discusses the strategic reasoning behind a U.S. IPO, how one should go about it, as well as the challenges and key learnings

11.45 - 12.45 PM

12.45 - 1.45 PM

1.45 - 2.30 PM

Company presentations 

Networking lunch

Panel debate: Investing in Scandinavia

Investors are actively looking at investing in Scandinavian life science and biotech companies; alone in 2019, foreign investments in Danish Life science contributed with DKK 10bn*. This session provides an overview of why investors are looking to Scandinavia, what they are looking for specifically (i.e. how you can secure U.S. investments), and what they experience as the most common pitfalls for Scandinavian start-ups/companies. The session also aims to debate the local environments and regulations in each Scandinavian country that sometimes makes it difficult for foreign investors to navigate

*see "the economic footprint of life science

292 Main Street, Floors 3-7, Cambridge, MA 02142, United States

2.30 - 3.30 PM

3.30 - 5.00 PM

6.00 - 8.00 PM

Company presentations 

1:1 meetings

Formal reception

April 7, 2022
700 Technology Square 

Cambridge, MA 02139

8.30 - 9.00 AM 

9.00 - 9.45 AM 

Breakfast & registration

Panel debate: U.S. healthcare trends and priorities

The U.S. has arguably one of the most complex healthcare systems in the world and the healthcare agenda changes with the changing U.S. administration. This session presents and discusses the outlook for developments in Washington and the impact on the healthcare and biotech industry, as well as how the proposed changes may shape the future for non-U.S. companies doing business in U.S.

9.45 - 10.45 AM 

Company presentations

10.45 - 11.00 AM 

Networking coffee break 

11.00 - 11.45 AM

Panel debate: Accessing the U.S. market

For many life science companies, the U.S. market has a huge revenue and success potential. However, entering the market can be a challenge and there are many things to consider. This session touches upon some of the things that are relevant for a foreign start-up/company to consider, e.g., deciding on the strategy for U.S. presence, pricing and reimbursement, regulatory setup, trial design etc.

11.45 - 12.00 PM

12:00 - 1.00 PM

1:00 - 5.00 PM

Closing remarks

Networking lunch

1:1 meetings 

bottom of page